Emma García Melchor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Emma García Melchor has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Olivé Marqués
6 shared publicationsJ. Yagüe
Immunology Department, Hospital Clinic Barcelona, Barcelona, Spain
4 shared publicationsLourdes Mateo Soria
4 shared publicationsM. Juan
Immunology Department, Hospital Clinic Barcelona
4 shared publicationsElisabet García Casares
Sección de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España
3 shared publicationsM. Guma
Division of Rheumatology, Allergy and Immunology, UC San Diego School of Medicine, La Jolla, CA, United States
3 shared publications
Latest Publications
- Open Access
- 1 August 2021
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 80 (8) , 1075-1085
Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease
Objectives Increasing evidence suggests that inflammatory mechanisms play a key role in chronic tendon disease. After observing T cell signatures in human tendinopathy, we explored the interaction between T cells and tendon stromal cells or tenocytes to define their functional contribution to tissue remodelling and inflammation amplification and hence disease perpetuation. Methods T cells were quantified and characterised in healthy and tendinopathic tissues by flow cytometry (FACS), imaging mass cytometry (IMC) and single cell RNA-seq. Tenocyte activation induced by conditioned media from primary damaged tendon or interleukin-1β was evaluated by qPCR. The role of tenocytes in regulating T cell migration was interrogated in a standard transwell membrane system. T cell activation (cell surface markers by FACS and cytokine release by ELISA) and changes in gene expression in tenocytes (qPCR) were assessed in cocultures of T cells and explanted tenocytes. Results Significant quantitative differences were observed in healthy compared with tendinopathic tissues. IMC showed T cells in close proximity to tenocytes, suggesting tenocyte–T cell interactions. On activation, tenocytes upregulated inflammatory cytokines, chemokines and adhesion molecules implicated in T cell recruitment and activation. Conditioned media from activated tenocytes induced T cell migration and coculture of tenocytes with T cells resulted in reciprocal activation of T cells. In turn, these activated T cells upregulated production of inflammatory mediators in tenocytes, while increasing the pathogenic collagen 3/collagen 1 ratio. Conclusions Interaction between T cells and tenocytes induces the expression of inflammatory cytokines/chemokines in tenocytes, alters collagen composition favouring collagen 3 and self-amplifies T cell activation via an auto-regulatory feedback loop. Selectively targeting this adaptive/stromal interface may provide novel translational strategies in the management of human tendon disorders.
- 1 August 2021
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 80 (8) , 1075-1085
Open AccessNovel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease
Objectives Increasing evidence suggests that inflammatory mechanisms play a key role in chronic tendon disease. After observing T cell signatures in human tendinopathy, we explored the interaction between T cells and tendon stromal cells or tenocytes to define their functional contribution to tissue remodelling and inflammation amplification and hence disease perpetuation. Methods T cells were quantified and characterised in healthy and tendinopathic tissues by flow cytometry (FACS), imaging mass cytometry (IMC) and single cell RNA-seq. Tenocyte activation induced by conditioned media from primary damaged tendon or interleukin-1β was evaluated by qPCR. The role of tenocytes in regulating T cell migration was interrogated in a standard transwell membrane system. T cell activation (cell surface markers by FACS and cytokine release by ELISA) and changes in gene expression in tenocytes (qPCR) were assessed in cocultures of T cells and explanted tenocytes. Results Significant quantitative differences were observed in healthy compared with tendinopathic tissues. IMC showed T cells in close proximity to tenocytes, suggesting tenocyte–T cell interactions. On activation, tenocytes upregulated inflammatory cytokines, chemokines and adhesion molecules implicated in T cell recruitment and activation. Conditioned media from activated tenocytes induced T cell migration and coculture of tenocytes with T cells resulted in reciprocal activation of T cells. In turn, these activated T cells upregulated production of inflammatory mediators in tenocytes, while increasing the pathogenic collagen 3/collagen 1 ratio. Conclusions Interaction between T cells and tenocytes induces the expression of inflammatory cytokines/chemokines in tenocytes, alters collagen composition favouring collagen 3 and self-amplifies T cell activation via an auto-regulatory feedback loop. Selectively targeting this adaptive/stromal interface may provide novel translational strategies in the management of human tendon disorders.
- 22 January 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1780-1791
Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice
- 22 January 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1780-1791
Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice
- 1 December 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (12) , 2386-2397
Differential Requirement for CCR6 in IL-23–Mediated Skin and Joint Inflammation
- 1 December 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (12) , 2386-2397
Differential Requirement for CCR6 in IL-23–Mediated Skin and Joint Inflammation
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 904-905
AB0044 Assessment of Inflammasome Activation and Monocyte Subpopulations in Patients with Gout
Background Macrophages initiate the inflammatory response to monosodium urate (MSU) crystals and produce inflammatory cytokines and chemokines that induce migration of blood monocytes to further amplify the inflammatory response. One of the questions that remain unanswered is why some patients with hyperuricemia, and even with MSU deposits, remain clinically asymptomatic. Different subpopulations of blood monocytes have been recognised: classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical (CD14+CD16++); characteristically intermediate monocytes are expanded in infectious and inflammatory diseases and are associated with atherosclerosis.[1][2] Objectives To investigate the possibility that inflammasome reactivity to MSU crystals could influence the clinical expression of gout and to analyse the distribution of monocyte subpopulations in patients with gout. Methods 17 patients with gout (13 asymptomatic and 4 during an acute flare) and 19 healthy controls were selected. Inflammasome activation after stimulation with MSU (200 μg/ml), ATP (5mM) and nigericin (20 μg/mL) was assessed in peripheral blood mononuclear cells (PBMCs) by flow cytometry using Caspase-1 FLICA™ Detection Kit (Immunochemistry Technologies). Phagocytosis of MSU crystals was quantified by flow cytometry. PBMCs were cultured for 24 hours in the presence of MSU (200 μg/ml), LPS (100 ng/ml) or both and IL-1β was quantified by ELISA. Samples of peripheral blood were stained with CD45, HLA-DR, CD16, and CD14 antibodies. Uric acid, creatinine and C-reactive protein (CRP) were quantified in sera. Flow cytometry and statistics analysis were performed with the FACSDiva and GraphPad Prism 5. Results No differences were observed in active caspase-1 at baseline. However, when stimulated with MSU, monocytes from gout patients exhibited a higher increase of active caspase-1 (mean ± SEM, gout 2.20±0.15, controls 1.66±0.18, p=0.0419). Differences in phagocytosis of MSU crystals were excluded, as in both groups monocytes exhibited equivalent phagocytic capability. Unexpectedly, PBMCs of patients with gout exhibited diminished IL-1β production when challenged with LPS and MSU (p=0.0473). Regarding monocyte subpopulations, the intermediate phenotype was expanded in patients with gout during an acute flare and a weak correlation between intermediate monocytes and CRP was observed. Conclusions Monocytes of patients with gout exhibit an enhanced inflammasome activation with MSU crystals, suggesting that a reduced threshold in the inflammatory response could be involved in the development of clinical gout. However, for unknown reasons they produced less IL-1β upon stimulation. The expansion of intermediate monocytes was observed during gout flares and, although it cannot be excluded that intermediate monocytes could be “innocent bystanders” in the context of inflammation, it could suggest that these monocytes participate in the inflammatory response to MSU crystals. References Heine G. Nat Rev Nephrol 2012;8(6):362-9. Rossol M. Arthritis Rheum 2012;64(3):671-7. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 904-905
AB0044 Assessment of Inflammasome Activation and Monocyte Subpopulations in Patients with Gout
Background Macrophages initiate the inflammatory response to monosodium urate (MSU) crystals and produce inflammatory cytokines and chemokines that induce migration of blood monocytes to further amplify the inflammatory response. One of the questions that remain unanswered is why some patients with hyperuricemia, and even with MSU deposits, remain clinically asymptomatic. Different subpopulations of blood monocytes have been recognised: classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical (CD14+CD16++); characteristically intermediate monocytes are expanded in infectious and inflammatory diseases and are associated with atherosclerosis.[1][2] Objectives To investigate the possibility that inflammasome reactivity to MSU crystals could influence the clinical expression of gout and to analyse the distribution of monocyte subpopulations in patients with gout. Methods 17 patients with gout (13 asymptomatic and 4 during an acute flare) and 19 healthy controls were selected. Inflammasome activation after stimulation with MSU (200 μg/ml), ATP (5mM) and nigericin (20 μg/mL) was assessed in peripheral blood mononuclear cells (PBMCs) by flow cytometry using Caspase-1 FLICA™ Detection Kit (Immunochemistry Technologies). Phagocytosis of MSU crystals was quantified by flow cytometry. PBMCs were cultured for 24 hours in the presence of MSU (200 μg/ml), LPS (100 ng/ml) or both and IL-1β was quantified by ELISA. Samples of peripheral blood were stained with CD45, HLA-DR, CD16, and CD14 antibodies. Uric acid, creatinine and C-reactive protein (CRP) were quantified in sera. Flow cytometry and statistics analysis were performed with the FACSDiva and GraphPad Prism 5. Results No differences were observed in active caspase-1 at baseline. However, when stimulated with MSU, monocytes from gout patients exhibited a higher increase of active caspase-1 (mean ± SEM, gout 2.20±0.15, controls 1.66±0.18, p=0.0419). Differences in phagocytosis of MSU crystals were excluded, as in both groups monocytes exhibited equivalent phagocytic capability. Unexpectedly, PBMCs of patients with gout exhibited diminished IL-1β production when challenged with LPS and MSU (p=0.0473). Regarding monocyte subpopulations, the intermediate phenotype was expanded in patients with gout during an acute flare and a weak correlation between intermediate monocytes and CRP was observed. Conclusions Monocytes of patients with gout exhibit an enhanced inflammasome activation with MSU crystals, suggesting that a reduced threshold in the inflammatory response could be involved in the development of clinical gout. However, for unknown reasons they produced less IL-1β upon stimulation. The expansion of intermediate monocytes was observed during gout flares and, although it cannot be excluded that intermediate monocytes could be “innocent bystanders” in the context of inflammation, it could suggest that these monocytes participate in the inflammatory response to MSU crystals. References Heine G. Nat Rev Nephrol 2012;8(6):362-9. Rossol M. Arthritis Rheum 2012;64(3):671-7. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 201
THU0023 Soluble Uric Acid Exerts a Suppressive Effect on the Response of Macrophages to Monosodium Urate Crystals
Background There is extensive published literature about the interaction of monosodium urate (MSU) crystals with immune cells, however, less information exists about the impact of soluble uric acid (SUA) on these cells. As deposits of MSU crystals can be present in asymptomatic joints,[1] and changes in uric acid levels can initiate an arthritis flare in gout patients,[2] we investigated the effect of SUA on the response of macrophages to MSU crystals. Objectives To analyze the effect of SUA on macrophage polarization and function of M-CSF polarized M2-like macrophages. Methods Blood was collected from healthy donors after informed consent. Peripheral blood mononuclear cells (PBMC) were separated from whole blood by centrifugation with a density gradient. Monocytes were then isolated by negative selection with magnetic beads and cultured for 1 week with M-CSF (20 ng/ml) in the presence or absence of biologically relevant concentrations of SUA (0.3 mM and 0.6 mM representing normouricemia and hyperuricemia respectively). Macrophages were then stimulated with MSU (200 μg/mL), LPS (100 ng/mL) or both for 18 hours. Alternatively, M-CSF polarized M2-like macrophages were generated and subsequently exposed to SUA for 24 hours prior to stimulation with MSU and LPS. MSU phagocytosis and cell viability were analyzed by flow cytometry. IL-1β and IL-10 concentrations in culture supernatants were quantified by ELISA. Flow cytometry and statistical analyses were performed with FACSDiva and GraphPad Prism 5 softwares respectively. Results M2 macrophages polarized in the presence of SUA produced less IL-1β upon challenging with MSU and LPS, that was most significant in conditions equivalent to hyperuricemia (0.6mM), whereas there was a modest inhibitory effect on IL-10 production only for macrophages exposed to high uric acid concentrations. On the other hand, exposure of already polarized macrophages to both low and high concentrations of SUA notably suppressed both IL-1β and IL-10 production. No differences in phagocytosis or cell viability were observed with exposure to SUA either during or after macrophage polarization. Conclusions Unexpectedly, our results show that SUA exerts a suppressive effect on MSU-induced IL-1β and IL-10 production by M-CSF polarized macrophages. To our knowledge this is the first time that the effect of SUA on macrophages has been analyzed. Uric acid lowering therapy has been associated with an increased risk of gout flares. Our results indicate that one mechanism contributing to the development of gout flares could be the diminution of the local regulatory effect of SUA on macrophage activation. References Pascal E. Br J Rheumatol 1995;34(8):724-6. [2] Latourte A. Rheumatology 2014;53(11):1920-6. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 201
THU0023 Soluble Uric Acid Exerts a Suppressive Effect on the Response of Macrophages to Monosodium Urate Crystals
Background There is extensive published literature about the interaction of monosodium urate (MSU) crystals with immune cells, however, less information exists about the impact of soluble uric acid (SUA) on these cells. As deposits of MSU crystals can be present in asymptomatic joints,[1] and changes in uric acid levels can initiate an arthritis flare in gout patients,[2] we investigated the effect of SUA on the response of macrophages to MSU crystals. Objectives To analyze the effect of SUA on macrophage polarization and function of M-CSF polarized M2-like macrophages. Methods Blood was collected from healthy donors after informed consent. Peripheral blood mononuclear cells (PBMC) were separated from whole blood by centrifugation with a density gradient. Monocytes were then isolated by negative selection with magnetic beads and cultured for 1 week with M-CSF (20 ng/ml) in the presence or absence of biologically relevant concentrations of SUA (0.3 mM and 0.6 mM representing normouricemia and hyperuricemia respectively). Macrophages were then stimulated with MSU (200 μg/mL), LPS (100 ng/mL) or both for 18 hours. Alternatively, M-CSF polarized M2-like macrophages were generated and subsequently exposed to SUA for 24 hours prior to stimulation with MSU and LPS. MSU phagocytosis and cell viability were analyzed by flow cytometry. IL-1β and IL-10 concentrations in culture supernatants were quantified by ELISA. Flow cytometry and statistical analyses were performed with FACSDiva and GraphPad Prism 5 softwares respectively. Results M2 macrophages polarized in the presence of SUA produced less IL-1β upon challenging with MSU and LPS, that was most significant in conditions equivalent to hyperuricemia (0.6mM), whereas there was a modest inhibitory effect on IL-10 production only for macrophages exposed to high uric acid concentrations. On the other hand, exposure of already polarized macrophages to both low and high concentrations of SUA notably suppressed both IL-1β and IL-10 production. No differences in phagocytosis or cell viability were observed with exposure to SUA either during or after macrophage polarization. Conclusions Unexpectedly, our results show that SUA exerts a suppressive effect on MSU-induced IL-1β and IL-10 production by M-CSF polarized macrophages. To our knowledge this is the first time that the effect of SUA on macrophages has been analyzed. Uric acid lowering therapy has been associated with an increased risk of gout flares. Our results indicate that one mechanism contributing to the development of gout flares could be the diminution of the local regulatory effect of SUA on macrophage activation. References Pascal E. Br J Rheumatol 1995;34(8):724-6. [2] Latourte A. Rheumatology 2014;53(11):1920-6. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 904
AB0043 Effect of Macrophage Polarization in the Response to Uric Acid Crystals
Background Macrophages have been involved in both initiation and resolution of gout flares.1,2 These cells are characterised by their plasticity as the environment modulates their phenotype exerting inflammatory or anti-inflammatory functions depending on their activation or polarisation state.3 Macrophages in the presence of interferon-γ and lipopolysaccharide (LPS), what is known as classical activation, acquire an inflammatory phenotype and are also termed M1 macrophages. On the other hand, M2 or alternatively activated macrophages with IL-4 exhibit anti-inflammatory and homeostatic functions. Equivalently, in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) macrophages become M1 or M2, respectively. As M-CSF is present in the blood stream at steady state, some authors propose that M2 macrophages polarised with M-CSF could represent the population of resident macrophages. Objectives To investigate the response of polarised macrophages to monosodium urate (MSU) crystals in vitro. Methods Macrophages were derived from peripheral blood monocytes of healthy donors after informed consent. Peripheral blood mononuclear cells were separated from whole blood by centrifugation with a density gradient. Monocytes were then isolated by negative selection with magnetic beads and cultured for 1 week with GM-CSF (1000 I.U./mL) or M-CSF (20 ng/mL) to obtain M1 or M2 macrophages, respectively. Macrophages were then stimulated with MSU crystals (200 μg/ml), LPS (100 ng/ml) or both for 18 hours and quantification of IL-1β and IL-10 in supernatants was performed by ELISA. Activation of caspase-1 was analyzed by flow cytometry with the Caspase-1 FLICA™ Detection Kit (Immunochemistry Technologies). Cytoplasmic pro-caspase-1 and pro-IL-1β were analysed by western blot. Flow cytometry and statistics analysis were performed with the FACSDiva and GraphPad Prism 5. Results As expected, M1 macrophages produced inflammatory cytokines in response to LPS, whereas M2 macrophages produced IL-10. Both M1 and M2 failed to produce IL-1β after MSU stimulation. However, when challenged with MSU and LPS, M2 macrophages produced IL-1β and reduced IL-10 production. Resting M2 macrophages exhibited lower levels of active caspase-1 and pro-caspase-1 compared with M1. MSU stimulation increased active caspase-1 levels in both M1 and M2 macrophages and the presence of MSU and LPS had a synergic effect in pro-IL-1β. Conclusions M1 and M2 macrophages failed to produce inflammatory cytokines after MSU challenging, according with the fact that MSU crystals can be found in asymptomatic joints. However, after MSU phagocytosis and LPS stimulation, M2 macrophages were able to produce IL-1β, as MSU crystals activated caspase-1 and LPS induced pro-IL-1β. This fact explains the requirement of a trigger for the initiation of an acute flare in gout. M2 macrophages exhibited lower levels of caspase-1 and pro-caspase-1 than M1 macrophages. References Yagnik D. Arthritis and Rheum. 2004;50(7):2273-8. Martin WJ. Arthritis and Rheum. 2009;60(1):281-89. Mosser DM. Nat Rev Immunol. 2008;8(12):958-69. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 904
AB0043 Effect of Macrophage Polarization in the Response to Uric Acid Crystals
Background Macrophages have been involved in both initiation and resolution of gout flares.1,2 These cells are characterised by their plasticity as the environment modulates their phenotype exerting inflammatory or anti-inflammatory functions depending on their activation or polarisation state.3 Macrophages in the presence of interferon-γ and lipopolysaccharide (LPS), what is known as classical activation, acquire an inflammatory phenotype and are also termed M1 macrophages. On the other hand, M2 or alternatively activated macrophages with IL-4 exhibit anti-inflammatory and homeostatic functions. Equivalently, in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) macrophages become M1 or M2, respectively. As M-CSF is present in the blood stream at steady state, some authors propose that M2 macrophages polarised with M-CSF could represent the population of resident macrophages. Objectives To investigate the response of polarised macrophages to monosodium urate (MSU) crystals in vitro. Methods Macrophages were derived from peripheral blood monocytes of healthy donors after informed consent. Peripheral blood mononuclear cells were separated from whole blood by centrifugation with a density gradient. Monocytes were then isolated by negative selection with magnetic beads and cultured for 1 week with GM-CSF (1000 I.U./mL) or M-CSF (20 ng/mL) to obtain M1 or M2 macrophages, respectively. Macrophages were then stimulated with MSU crystals (200 μg/ml), LPS (100 ng/ml) or both for 18 hours and quantification of IL-1β and IL-10 in supernatants was performed by ELISA. Activation of caspase-1 was analyzed by flow cytometry with the Caspase-1 FLICA™ Detection Kit (Immunochemistry Technologies). Cytoplasmic pro-caspase-1 and pro-IL-1β were analysed by western blot. Flow cytometry and statistics analysis were performed with the FACSDiva and GraphPad Prism 5. Results As expected, M1 macrophages produced inflammatory cytokines in response to LPS, whereas M2 macrophages produced IL-10. Both M1 and M2 failed to produce IL-1β after MSU stimulation. However, when challenged with MSU and LPS, M2 macrophages produced IL-1β and reduced IL-10 production. Resting M2 macrophages exhibited lower levels of active caspase-1 and pro-caspase-1 compared with M1. MSU stimulation increased active caspase-1 levels in both M1 and M2 macrophages and the presence of MSU and LPS had a synergic effect in pro-IL-1β. Conclusions M1 and M2 macrophages failed to produce inflammatory cytokines after MSU challenging, according with the fact that MSU crystals can be found in asymptomatic joints. However, after MSU phagocytosis and LPS stimulation, M2 macrophages were able to produce IL-1β, as MSU crystals activated caspase-1 and LPS induced pro-IL-1β. This fact explains the requirement of a trigger for the initiation of an acute flare in gout. M2 macrophages exhibited lower levels of caspase-1 and pro-caspase-1 than M1 macrophages. References Yagnik D. Arthritis and Rheum. 2004;50(7):2273-8. Martin WJ. Arthritis and Rheum. 2009;60(1):281-89. Mosser DM. Nat Rev Immunol. 2008;8(12):958-69. Disclosure of Interest None declared
- 1 July 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (7) , 1566-1567
CIAS1 and NOD2 Genes in Adult-onset Still’s Disease
- 1 July 2014
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (7) , 1566-1567
CIAS1 and NOD2 Genes in Adult-onset Still’s Disease
- 1 June 2013
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 72 (Suppl 3) , A786
AB0002 Analysis of nlrp3 and nod2 genes in adult onset still's disease
Background Adult Onset Still’s Disease (AOSD) is a systemic inflammatory disease characterized by fever, skin rash, articular involvement, lymphadenopathy, hepatosplenomegaly and serositis. Due to the absence of autoantibodies and autoantigen-specific T cells and the efficacy of treatment with IL-1β blocking agents, AOSD has been considered an autoinflammatory disease. Some entities of this group are inherited diseases caused by mutations in genes related with the processing of IL-1β. The cryopyrinopathies are caused by heterozygous gain-of-function mutations in NLRP3 gene (Nucleotide-binding domain Leucine Rich repeat family Pyrin domain containing 3) and share some clinical features with AOSD like fever, cutaneous and musculoskeletal involvement and serositis. Heterozygous gain-of-function NOD2 (Nucleotide Oligomerization Domain 2) mutations are associated with Blau syndrome, which is characterized by uveitis and, like AOSD, fever and chronic arthritis. Objectives The aim of this study is to analyze the potential involvement of mutations in the NALP3 and NOD2 genes in AOSD patients. Methods Eighteen patients with AOSD from two hospitals in Spain were enrolled. All the patients fulfilled the Yamaguchi criteria and informed consent was obtained from each participant. The study protocol was approved by the ethics committee from the Hospital Universitari Germans Trias i Pujol. Genomic DNA was extracted from whole blood using the Roche MagNAPure Compact (Roche Diagnostics, Indianapolis, IN). Exon 4 of NOD2 gene (GeneBank NM 022162.1) and exon 3 of NLRP3 gene (GeneBank NM 001243133.1) were amplified by polymerase chain reaction. Bidirectional fluorescence sequencing was performed using an ABI BigDye Terminator version 3.1 Cycle Sequencing kit and run on a 3730XL DNA Analyzer. As control population, the European Caucasic samples from 1000 Genome Project (n=379) were used. Differences in frequencies of alleles and genotypes between AOSD patients and controls were examined using the Chi-squared method, Fisher’s exact test and logistic regression with Statistical Analysis Software (SAS). Results Most AOSD patients showed no pathogenic variants in NALP3 or NOD2 gene. Of interest, two patients were carriers of a NOD2 polymorphism associated with Crohn disease (p.R702W, rs206684) without having any symptom suggestive of inflammatory bowel disease, and another one was carrier of a rare NOD2 variant of uncertain significance that was previously reported in a patient with spondyloarthritis (p.R791Q, rs104895464). In the NLRP3 analysis, one patient was carrier of the variant of uncertain significance p.V198M (rs121908147). Conclusions AOSD has some similarities with inherited autoinflammatory syndromes like the clinical presentation and the efficacy of treatment with IL-1β blocking agents. Although in our series none of the AOSD patients carried a true disease-associated mutation, the possibility of an inherited autoinflammatory disease should be considered in the differential diagnosis and ruled out by means of genetic analysis. Disclosure of Interest None Declared
- 1 June 2013
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 72 (Suppl 3) , A786
AB0002 Analysis of nlrp3 and nod2 genes in adult onset still's disease
Background Adult Onset Still’s Disease (AOSD) is a systemic inflammatory disease characterized by fever, skin rash, articular involvement, lymphadenopathy, hepatosplenomegaly and serositis. Due to the absence of autoantibodies and autoantigen-specific T cells and the efficacy of treatment with IL-1β blocking agents, AOSD has been considered an autoinflammatory disease. Some entities of this group are inherited diseases caused by mutations in genes related with the processing of IL-1β. The cryopyrinopathies are caused by heterozygous gain-of-function mutations in NLRP3 gene (Nucleotide-binding domain Leucine Rich repeat family Pyrin domain containing 3) and share some clinical features with AOSD like fever, cutaneous and musculoskeletal involvement and serositis. Heterozygous gain-of-function NOD2 (Nucleotide Oligomerization Domain 2) mutations are associated with Blau syndrome, which is characterized by uveitis and, like AOSD, fever and chronic arthritis. Objectives The aim of this study is to analyze the potential involvement of mutations in the NALP3 and NOD2 genes in AOSD patients. Methods Eighteen patients with AOSD from two hospitals in Spain were enrolled. All the patients fulfilled the Yamaguchi criteria and informed consent was obtained from each participant. The study protocol was approved by the ethics committee from the Hospital Universitari Germans Trias i Pujol. Genomic DNA was extracted from whole blood using the Roche MagNAPure Compact (Roche Diagnostics, Indianapolis, IN). Exon 4 of NOD2 gene (GeneBank NM 022162.1) and exon 3 of NLRP3 gene (GeneBank NM 001243133.1) were amplified by polymerase chain reaction. Bidirectional fluorescence sequencing was performed using an ABI BigDye Terminator version 3.1 Cycle Sequencing kit and run on a 3730XL DNA Analyzer. As control population, the European Caucasic samples from 1000 Genome Project (n=379) were used. Differences in frequencies of alleles and genotypes between AOSD patients and controls were examined using the Chi-squared method, Fisher’s exact test and logistic regression with Statistical Analysis Software (SAS). Results Most AOSD patients showed no pathogenic variants in NALP3 or NOD2 gene. Of interest, two patients were carriers of a NOD2 polymorphism associated with Crohn disease (p.R702W, rs206684) without having any symptom suggestive of inflammatory bowel disease, and another one was carrier of a rare NOD2 variant of uncertain significance that was previously reported in a patient with spondyloarthritis (p.R791Q, rs104895464). In the NLRP3 analysis, one patient was carrier of the variant of uncertain significance p.V198M (rs121908147). Conclusions AOSD has some similarities with inherited autoinflammatory syndromes like the clinical presentation and the efficacy of treatment with IL-1β blocking agents. Although in our series none of the AOSD patients carried a true disease-associated mutation, the possibility of an inherited autoinflammatory disease should be considered in the differential diagnosis and ruled out by means of genetic analysis. Disclosure of Interest None Declared
- 1 July 2011
- Published by Elsevier in Medicina Clinica
- Vol. 137 (5) , 236-237
Arteritis de Takayasu: ¿infrecuente o poco diagnosticada?
- 1 July 2011
- Published by Elsevier in Medicina Clinica
- Vol. 137 (5) , 236-237
Arteritis de Takayasu: ¿infrecuente o poco diagnosticada?
- 1 December 2010
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 16 (8) , 382-384
Necrotizing Fasciitis and Myositis Caused by Streptococcal Flesh-Eating Bacteria
Three types of group A streptococcal infections are particularly feared: necrotizing fasciitis, myositis, and streptococcal toxic shock syndrome (TSS). We present 3 cases of necrotizing fasciitis due to Streptococcus pyogenes, one in an immunocompromised patient who had received kidney transplant and 2 healthy patients. Mean age of patients was 52 years (range, 42-67 years), and all 3 were male. One spontaneous case in absence of any obvious portal of entry is reported. The clinical course was initially indolent but quickly destructive. All patients required emergency surgical debridement and intravenous antibiotics. In 2 cases, intravenous immunoglobulin therapy was added. Differential diagnoses include septic arthritis, cellulitis, gout, other causes of tenosynovitis, erysipelas, and deep vein thrombosis.Blood and soft-tissue cultures should be obtained to identify the bacteria, and emergency computed tomography or magnetic resonance imaging scan should be performed to confirm the diagnosis and define the extension of the necrosis. Aggressive surgical debridement in the first 24 to 48 hours and antibiotic treatment, including penicillin and clindamycin, are the cornerstones in the management of these infections. Adjuvant intravenous immunoglobulin therapy might be useful in case of TSS. Diagnostic and treatment delays are the main causes of mortality in these infections.
- 1 December 2010
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 16 (8) , 382-384
Necrotizing Fasciitis and Myositis Caused by Streptococcal Flesh-Eating Bacteria
Three types of group A streptococcal infections are particularly feared: necrotizing fasciitis, myositis, and streptococcal toxic shock syndrome (TSS). We present 3 cases of necrotizing fasciitis due to Streptococcus pyogenes, one in an immunocompromised patient who had received kidney transplant and 2 healthy patients. Mean age of patients was 52 years (range, 42-67 years), and all 3 were male. One spontaneous case in absence of any obvious portal of entry is reported. The clinical course was initially indolent but quickly destructive. All patients required emergency surgical debridement and intravenous antibiotics. In 2 cases, intravenous immunoglobulin therapy was added. Differential diagnoses include septic arthritis, cellulitis, gout, other causes of tenosynovitis, erysipelas, and deep vein thrombosis.Blood and soft-tissue cultures should be obtained to identify the bacteria, and emergency computed tomography or magnetic resonance imaging scan should be performed to confirm the diagnosis and define the extension of the necrosis. Aggressive surgical debridement in the first 24 to 48 hours and antibiotic treatment, including penicillin and clindamycin, are the cornerstones in the management of these infections. Adjuvant intravenous immunoglobulin therapy might be useful in case of TSS. Diagnostic and treatment delays are the main causes of mortality in these infections.